PR Newswire (press release) TUCSON, Ariz., June 4, 2013 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant ... 更多 »
Wall Street Journal (press release) Theradiag (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics , today announced that it is significantly strengthening its activities in ... 更多 »
GlobeNewswire (press release) In completed Phase 1/2 trials of NeuVax™ (nelipepimut-S), patients who exhibit robust in vitro immunologic response have lower recurrence rates. NeuVax companion diagnostic , the Leica Bond Oracle HER2 IHC assay, improves the accuracy of HER2 protein ... 更多 »
Wall Street Journal (press release) The nCounter-based Prosigna(TM) Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic kit to be marketed through the company's recently formed diagnostics business. 更多 »
Lexology (registration) This type of letter appears to be a practice that the Office of In Vitro Diagnostics and Radiological Health ("OIR") uses when addressing areas of regulatory uncertainty. For example, OIR has previously ... 更多 »
PR Newswire (press release) Under terms of the private placement, which raised $4.7 million in gross proceeds, Ampio will retain approximately 80% ownership of the newly formed in-vitro diagnostics company focused on the ... 更多 »
Wired What James Woods, the FDA's Deputy Director of Patient Safety And Product Quality in the Office of In Vitro Diagnostics and Radiological Health , sent him recently was an “It Has Come to Our Attention ...
Wall Street Journal The nCounter-based Prosigna(TM) Breast Cancer Prognostic Gene Signature Assay is the first in vitro diagnostic kit to be marketed through the company's recently formed diagnostics business.
